Honeybees play role in developing new antibiotics: Study

Honeybees could play a role in developing new antibiotics: Study

5:19 AM, 25th September 2017
Honeybees can play a role in developing new antibiotics: Study
Api137 is a natural product produced by bees, wasps or hornets.

CHICAGO, US: An antimicrobial compound made by honeybees could become the basis for new antibiotics, according to new research at the University of Illinois at Chicago (UIC).

No new antibiotics have been discovered for more than 30 years, and some bacteria are becoming immune to the drugs used to treat or prevent infections. Antibiotic resistance called one of the world’s most pressing public health concerns by the Centers for Disease Control and Prevention, can mean illnesses that were once easily treatable are now potentially deadly.

In a new study published in the journal Nature Structural & Molecular Biology, UIC researchers, led by co-investigators Alexander Mankin and Nora Vazquez-Laslop of the College of Pharmacy’s Center for Biomolecular Sciences, explained how a derivative of the antibiotic apidaecin (Api137) can block the production of proteins in potentially harmful bacteria.

Many antibiotics kill bacteria by targeting the ribosome, which makes all the proteins in the cell. Protein production can be halted by interfering with different stages of translation the process by which DNA is “translated” into protein molecules, Mankin said. Api137 is the first known inhibitor of translation termination, he added.

Api137 is a natural product produced by bees, wasps or hornets. In nature, many organisms defend themselves from infection by making antibacterial peptides, or small proteins. The peptides can be used as antibiotics if “we understand how they work,” said Tanja Florin, a UIC doctoral student who served as one of the lead authors on the paper.

“This project was a result of an excellent collaboration of our team,” said Vázquez-Laslop, who worked with two research groups in Germany. “We can now harness the knowledge of how Api137 works in order to make new drugs that would kill bad bacteria using a similar mechanism of action.”

Co-authors include Dorota Klepacki, UIC; Marina Rodnina, Cristina Maracci and Prajwal Karki, Max Planck Institute for Biophysical Chemistry, Gottingen, Germany; and Daniel Wilson, Michael Graf, Otto Berninghausen and Roland Beckmann, University of Munich, Munich, Germany.

The research was funded by National Institutes of Health; iNEXT project 2259; grants of the Forschergruppe FOR 1805; and a project grant in the framework of the Sonderforschungsbereich SFB860 from the Deutsche Forschungsgemeinschaft.

© University of Illinois at Chicago



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Covestro, PPG’s first automotive refinish coating with bio-based hardener

LEVERKUSEN, GERMANY: Electric mobility and photovoltaics play a vital role in protecting the climate and conserving fossil resources. Combining them l ...

Read more
LyondellBasell starts production at new compounding plant in China

HOUSTON, US/ ROTTERDAM, THE NETHERLANDS: LyondellBasell Industries NV has started up production at a new 20 kilotonne per year polypropylene (PP) comp ...

Read more
DSM to acquire Dutch animal nutrition firm Twilmij

HEERLEN, NETHERLANDS: Royal DSM said that it is acquiring Twilmij BV (Twilmij), a well-established Dutch nutritional solutions company in the ani ...

Read more
Total joins with Chevron in Gulf of Mexico exploration

PARIS, FRANCE: Total SA (TOT) said that its subsidiary, Total E&P USA Inc (Total), has entered into an agreement to capture 7 prospects operated b ...

Read more
IFF opens expanded flavours site in Cairo, Egypt

NEW YORK, US: International Flavors & Fragrances Inc (IFF) has opened its fully renovated and expanded facility in Cairo, Egypt. The investment su ...

Read more
Covestro presents innovative material solutions for medical sector

LEVERKUSEN, GERMANY: Covestro AG said that it will be presenting itself as a key supplier of raw materials and partner to the medical technology secto ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X